Translational Development Acquisition Corp. - TDAC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jun 02, 2026 | SCHEDULE 13G | Linden Capital L.P. | 5.3% | 913,482 | View |
| Jun 02, 2026 | SCHEDULE 13G | Linden GP LLC | 5.3% | 913,482 | View |
| Jun 02, 2026 | SCHEDULE 13G | Linden Advisors LP | 5.5% | 950,000 | View |
| Jun 02, 2026 | SCHEDULE 13G | Siu Min Wong | 5.5% | 950,000 | View |
| May 13, 2026 | SCHEDULE 13G | THE GOLDMAN SACHS GROUP, INC. | 6.1% | 1,054,120 | View |
| May 13, 2026 | SCHEDULE 13G | GOLDMAN SACHS & CO. LLC | 6.1% | 1,054,120 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.